Clinical trials have demonstrated hemoglobin A1c reductions of 1.9% to 2.4% in patients with type 2 diabetes
New oral pill options include Amycretin, which contains GLP-1 and amylin, and Conveglipron, a new oral GLP-1 similar to Foundayo, which is currently in Phase 2-3 trials
Comprehensive complication management strategies, including those outlined on Diabetes In Control, emphasize early detection and multifactorial intervention
GLP-1 drugs have become widely available via online telehealth platforms, and in some cases, can be purchased directly from pharmaceutical companies websites where the public can buy these drugs without using their insurance
Concerns are that, without proper screening, those with prior mental health conditions could experience worse symptoms